[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Last week we saw the USD 2 billion buyout of Fusion Pharmaceuticals by AstraZeneca to accelerate the development of next-generation…
AstraZeneca CEO Pascal Soriot discusses the drugmaker’s business strategy in China, the US “BIOSECURE Act,” and future deals and partnerships…
The chief executive officers of AstraZeneca Plc and Pfizer Inc. pledged to support expansion of China’s biopharmaceutical industry, even as…
FDA approves AstraZenecas (AZN) Ultomiris for AQP4 Ab+ NMOSD, making it the first and only long-acting C5 complement inhibitor approved…
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Sell" mit einem Kursziel von 9900…
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower…
AstraZeneca (AZN) is set to acquire Fusion Biopharma (FUSN) for $21 per share in cash, along with a contingent value…
AstraZeneca (AZN) has offered to acquire Fusion for $21.00 per share in cash plus a contingent value (CV) payment of…
…
…
The company is working on radiopharmaceuticals treatments for cancer.…
Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…
AstraZeneca PLC (LSE:AZN) is acquiring Canadas Fusion Pharmaceuticals for $2.4 billion, in a bid to effectively keep up with Joneses…
The deal is AstraZenecas second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to…
Frankfurt (Reuters) - Der Pharmakonzern AstraZeneca verstärkt sich im Geschäft mit Krebsarzneien mit einem Milliardenzukauf.
Für rund zwei Milliarden Dollar…
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca will den kanadischen Krebsspezialisten Fusion Pharmaceuticals übernehmen. Dabei…
…
AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as it seeks to transform cancer…
AstraZeneca to buy Fusion Pharma for $2 billion in cash…
19 March 2024
AstraZeneca to acquire Fusion to accelerate the development of
next-generation radioconjugates to treat cancer
Includes actinium-based clinical-stage radioconjugate targeting PSMA…
AstraZeneca caps inhaler costs at $35 for eligible US patients…
AstraZeneca to cap US out-of-pocket costs for inhalers at $35 per month…
Kommunen fordern "Atempause" bei Flüchtlingen ++ EU schließt 7,4-Milliarden-Flüchtingsdeal mit Ägypten ++ Teilurteil in Corona-Prozess gegen AstraZeneca erwartet ++ neue…
AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lillys (LLY) donanemab and approves…
Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…
A rash of dealmaking helped reverse the declining fortunes of biotech stocks over the last five months. And as AstraZeneca…
Frankfurt (www.aktiencheck.de) - Rating-Update:
Die Analysten von ODDO BHF stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG,…
AstraZeneca will acquire Amolyt Pharma for up to $1.05 billion in total consideration…
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio…
14 March, 2024
AstraZeneca to acquire Amolyt Pharma,
expanding late-stage rare disease pipeline
Amolyt development portfolio includes Phase III asset with potential to address…
AstraZeneca (AZN) enters into an agreement to acquire Amolyt Pharma to strengthen its rare disease pipeline by adding the latters…
The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…
Companies covered in this study are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), AstraZeneca plc, Novartis AG, Johnson…
AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing…
AstraZeneca to invest 650 million pounds in UK to boost pandemic preparedness…
New York (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Guggenheim Securities:
Die Analysten von Guggenheim Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…
4 March 2024
Two datopotamab deruxtecan applications validated in the EU for
patients with advanced nonsquamous non-small cell lung
cancer or HR-positive, HER2-negative…
U.S. District Judge Colm Connollys decision comes one day before manufacturers have to respond to Medicares initial price offers for…
1 March 2024 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
Costco Wholesale, The Walt Disney, AstraZeneca, OReilly Automotive and Restaurant Brands International are part of the Zacks top Analyst Blog.…
Todays Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), The Walt Disney Company…
Since Prime Minister Margaret Thatcher unleashed a wave of privatizations in the 1980s, the London Stock Exchange has been a…
Aradhana Sarin led deals to expand AstraZenecas drug pipeline, and transformed the finance function to improve employee retention and productivity.…
The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place …
…
…
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell”…
22 February 2024
Acquisition of Gracell completed
AstraZeneca today announced the successful completion of the acquisition (https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-to-acquire-gracell-furthering-cell-therapy-ambition-across-oncology-and-autoimmune-diseases.html) of Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a…
22 February 2024 11:00 GMT
Transaction by Person Discharging Managerial Responsibilities
AstraZeneca PLC (the Company) announced that, on 20 February 2024, an…